Insmed (INSM) Amortization of Deferred Charges (2012 - 2026)

Insmed's Amortization of Deferred Charges history runs 15 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Amortization of Deferred Charges fell 24.15% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $4.9 million (down 74.36% YoY), while the FY2025 annual figure was $524000.0, down 97.28% from the prior year.
• Amortization of Deferred Charges was $1.4 million for Q1 2026 at Insmed, up from $524000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $14.1 million in Q4 2024 to a low of -$9.9 million in Q4 2023.
• Historically, Amortization of Deferred Charges has averaged $1.7 million across 5 years, with a median of $1.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges tumbled 347.61% in 2023, then soared 242.65% in 2024.
• A 5-year view of Amortization of Deferred Charges shows it stood at $4.0 million in 2022, then sank by 347.61% to -$9.9 million in 2023, then jumped by 242.65% to $14.1 million in 2024, then sank by 96.28% to $524000.0 in 2025, then soared by 163.74% to $1.4 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $1.4 million (Q1 2026), $524000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.